Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile
Effect of Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile in Obese Postmenopausal Women
1 other identifier
interventional
60
1 country
1
Brief Summary
Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 26, 2024
CompletedFirst Posted
Study publicly available on registry
March 4, 2024
CompletedJuly 22, 2024
July 1, 2024
1.3 years
February 26, 2024
July 19, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Waist/ hip ratio
anthropometric outcome measure for abdominal adiposity
Pretreatment and Posttreatment of six weeks study protocol.
Skin fold caliper
subcutaneous fat outcome measure
Pretreatment and Posttreatment of six weeks study protocol.
Secondary Outcomes (1)
Lipid profile
Pretreatment and Posttreatment of six weeks study protocol.
Study Arms (2)
Study Group (A) (ESWT)
ACTIVE COMPARATOR30 participants will receive Extracorporeal Shockwave (one session per week for 6 weeks), in addition to a balanced low-calorie diet (1500 k/cal for 6 weeks).
Control Group (B)
PLACEBO COMPARATOR30 participant will receive Balanced low-calorie diet (1500 k/cal for 6 weeks), only.
Interventions
2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.
Eligibility Criteria
You may qualify if:
- Their age range 45-60 years old.
- Their body mass index range 30-35 kg/m square.
- Only, obese postmenopausal women with at least one year after stoppage of menses.
You may not qualify if:
- Receiving pharmacological treatment.
- Receiving any form of electrotherapy.
- Whom with metabolic, hematological or renal dysfunction.
- Whom have dermatological or cardiovascular or respiratory, digestive or rheumatic disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Helwan General Hospital
Cairo, Helwan, Cairo Governate, 02, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Azza B Nashed, PHD
Professor of Physical Therapy for Women's Health
- STUDY DIRECTOR
Sherif S El-Shebeni, MSc.
Consultant of Obstetrics and Gynecology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double masking (Investigator and Participant)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Therapy
Study Record Dates
First Submitted
February 26, 2024
First Posted
March 4, 2024
Study Start
September 11, 2022
Primary Completion
January 1, 2024
Study Completion
February 1, 2024
Last Updated
July 22, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
Will Share whole raw data, therapeutic protocol details for future systematic review and/ or meta-analysis. wish to be valuable